Currently
traditional medicine (TM) is used in primary health care systems in most
countries parallel to conventional medicine. Therefore TM should be subjectedto rigorous research for their efficacy and safety for better health care. At
present there is a high necessity for evidence based clinical drug development
with changing of global economic scene. When developing novel drugs using TM
candidates it is essential to consider novel standard parameters whenever
possible. Quality control of TM is also prerequisite of standard clinical
trials.
When following evidence based clinical herbal product development cycle
it is necessary to follow current standard quality controlling methods viz Good
Laboratory Practice (GLP); Good Manufacturing Practice (GMP; Good Clinical
Practice (GCP); Chemistry, Manufacturing and Controls (CMC) or PharmaceuticalQuality. World Health Organization (WHO), 2004 has published guidelines for safety
issues in herbal product development. According to this categorization it is
required to be addressed safety and toxicity before clinical usage of TM.
No comments:
Post a Comment